Strong top- and bottom-line growth and significant market share gains, driven by unprecedented retail demand, flexible and resilient business model […]
NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]